Clinical Efficacy and Safety of Laparoscopic Sleeve Gastrectomy in Obese Patients With PCOS
Shanghai Tenth People's Hospital,School of Medicine, Tongji University
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
This study aims to evaluate the clinical efficacy and safety in obese patients with Polycystic Ovary Syndrome after laparoscopic sleeve gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 13, 2022
CompletedOctober 3, 2022
September 1, 2022
7.7 years
September 6, 2022
September 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Menstrual cycles
the total number of menstrual periods in the last year
3 years
Secondary Outcomes (29)
ZAG
3 years
FGF-19
3 years
FGL-1
3 years
BMI
3 years
Waist/hip Ratio
3 years
- +24 more secondary outcomes
Study Arms (2)
PCOS group
EXPERIMENTALObese Patients with PCOS underwent LSG
Control group
ACTIVE COMPARATORSample obese patients without PCOS underwent LSG
Interventions
Eligibility Criteria
You may qualify if:
- age ranged from 18\~45 years old,
- BMI over 37.5 kg/m2, or BMI over 32.5 kg/m2 with diabetes which meets the recommended cutoff for bariatric surgery of the Guidelines for surgical treatment of obesity accompanied with or without type 2 diabetes in China.
You may not qualify if:
- outside of the 18-45 age range;
- secondary obesity caused by endocrine disorders;
- history of more than one bariatric procedure;
- severe hepatic, renal or heart dysfunction;
- mental illnesses or intellectual disability.
- pregnancy or lactation
- contraindications for laparoscopic surgery, such as gastrointestinal diseases of intra-abdominal infection, adhesions, etc.,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 13, 2022
Study Start
May 1, 2013
Primary Completion
December 31, 2020
Study Completion
December 31, 2021
Last Updated
October 3, 2022
Record last verified: 2022-09